BACKGROUND
Vaccination with rVSV-ZEBOV is highly effective against Ebola virus, but protection against Bundibugyo virus (BDBV) is unproven. We evaluated the relative population impact and dose efficiency of a partially cross-protective hypothetical vaccine under operationally realistic constraints during a BDBV outbrea...
Jason R. Andrews, P. Mbala, P. Mukadi et al.· Lancet. Infectious Diseases...· 0 citations
The prevalence of LTBI among adults living with HIV in Kinshasa is high and severe immunosuppression, prior exposure, and contact with active TB cases are key determinants, highlighting the importance of screening and preventive therapy to reduce progression to active tuberculosis.
J. Kadima, A. Nkodila, P. Lutumba et al.· Public Health Challenges· 0 citations
The 2026 outbreak of Ebola virus disease caused by Bundibugyo virus shows that scientific innovation alone is insufficient; its public health impact depends on integrated, species-inclusive systems capable of rapidly detecting, evaluating, and responding to outbreaks caused by any human-pathogenic Orthoebolavirus spp.
The emergence of mpox as a global public health concern demands accurate and efficient molecular diagnostic tools for surveillance and outbreak management. The single-plex mpox virus (MPXV)-specific assays targeting B7R and TNF receptor (G2R) genes are widely used for this purpose. However, single-target approaches a...
Carmen Koo, J. Griffiths, Eugene Tan et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
